De novo designed proteins neutralize lethal snake venom toxins
Susana Vázquez Torres,Melisa Benard Valle,Stephen P Mackessy,Stefanie K Menzies,Nicholas R Casewell,Shirin Ahmadi,Nick J Burlet,Edin Muratspahić,Isaac Sappington,Max D Overath,Esperanza Rivera-de-Torre,Jann Ledergerber,Andreas H Laustsen,Kim Boddum,Asim K Bera,Alex Kang,Evans Brackenbrough,Iara A Cardoso,Edouard P Crittenden,Rebecca J Edge,Justin Decarreau,Robert J Ragotte,Arvind S Pillai,Mohamad Abedi,Hannah L Han,Stacey R Gerben,Analisa Murray,Rebecca Skotheim,Lynda Stuart,Lance Stewart,Thomas J A Fryer,Timothy P Jenkins,David Baker
DOI: https://doi.org/10.21203/rs.3.rs-4402792/v1
2024-05-17
Abstract:Snakebite envenoming remains a devastating and neglected tropical disease, claiming over 100,000 lives annually and causing severe complications and long-lasting disabilities for many more1,2. Three-finger toxins (3FTx) are highly toxic components of elapid snake venoms that can cause diverse pathologies, including severe tissue damage3 and inhibition of nicotinic acetylcholine receptors (nAChRs) resulting in life-threatening neurotoxicity4. Currently, the only available treatments for snakebite consist of polyclonal antibodies derived from the plasma of immunized animals, which have high cost and limited efficacy against 3FTxs5,6,7. Here, we use deep learning methods to de novo design proteins to bind short- and long-chain α-neurotoxins and cytotoxins from the 3FTx family. With limited experimental screening, we obtain protein designs with remarkable thermal stability, high binding affinity, and near-atomic level agreement with the computational models. The designed proteins effectively neutralize all three 3FTx sub-families in vitro and protect mice from a lethal neurotoxin challenge. Such potent, stable, and readily manufacturable toxin-neutralizing proteins could provide the basis for safer, cost-effective, and widely accessible next-generation antivenom therapeutics. Beyond snakebite, our computational design methodology should help democratize therapeutic discovery, particularly in resource-limited settings, by substantially reducing costs and resource requirements for development of therapies to neglected tropical diseases.